Global Lung Cancer Screening Software Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Jul 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Lung Cancer Screening Software Market, By Mode of Delivery (Cloud Based Solutions, On-premise Solutions, and Web Based Solutions), Type (Computer-Assisted Screening and Traditional Screening), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management and Audit Log Tracking), Application (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC), Platform (Standalone and Integrated), Purchase Mode (Institutional and Individual), End User (Oncology Centres, Hospitals, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tenders and Third Party Distributor), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.

Lung Cancer Screening Software Market Market Analysis and Insights : Global Lung Cancer Screening Software Market

Data Bridge Market Research analyses that the lung cancer screening software market will exhibit a CAGR of around 5.63% for the forecast period of 2021-2028. Ring cases of lung cancer around the globe, increased focus of technological advancements involved in the manufacturing of medical devices and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors responsible for the growth of lung cancer screening software market.

From the name itself, the role of lung cancer screening software is clear. Lung cancer screening software is used to screen, monitor and diagnose lung cancer in a patient. In other words, the lung cancer screening software helps to identify the patients at risk and automate the flow of data with integrated electronic health records.

Rising demand for innovative technologies in the treatment of non-small cell lung cancer is one of the major factors fostering the growth of lung cancer screening software market. Rising expenditure for research and development activities and rising personal disposable income are some other indirect lung cancer screening software market growth determinants. Rising number of screening programs across the globe will further generate lucrative lung cancer screening software market growth opportunities.

However, high costs associated with lung cancer treatment procedure in general will act as a market growth restraint. Lack of professional and medical expertise in developing and developed economies will further derail the lung cancer screening software market growth rate. Unfavourable reimbursement policies especially in the developing economies will further pose challenges for the lung cancer screening software market growth.

This lung cancer screening software market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lung cancer screening software market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Lung Cancer Screening Software Market Scope and Market Size

The lung cancer screening software market is segmented on the basis of mode of delivery, product, type, application, platform, purchase mode, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of mode of delivery, the lung cancer screening software market is segmented into cloud based solutions, on-premise solutions, and web based solutions.
  • On the basis of product, the lung cancer screening software market is segmented into lung cancer screening radiology solution, lung cancer screening patient management software, nodule management software, data collection and reporting, patient coordination and workflow, lung nodule computer aided detection, pathology and cancer staging, statistical audit reporting, screening PACs, practice management, and audit log tracking.
  • On the basis of type, the lung cancer screening software market is segmented into computer-assisted screening and traditional screening.
  • On the basis of application, the lung cancer screening software market is segmented into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
  • On the basis of platform, the lung cancer screening software market is segmented into standalone and integrated. On the basis of purchase mode, the lung cancer screening software market is segmented into individual and institutional.
  • On the basis of end user, the lung cancer screening software market is segmented into hospitals, oncology centers, ambulatory surgical centers, and others.
  • On the basis of distribution channel, the lung cancer screening software market is segmented into direct tenders, and third party distributor.

Lung Cancer Screening Software Market Country Level Analysis

The lung cancer screening software market is analysed and market size insights and trends are provided by country, mode of delivery, product, type, application, platform, purchase mode, end user, and distribution channel as referenced above.

The countries covered in the lung cancer screening software market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the lung cancer screening software market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the prevailing sophisticated level of healthcare facilities, on-going strategic partnerships and the presence of major key players in the region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the rising cases of lung cancer and increased expenditure on healthcare infrastructure.

The country section of the lung cancer screening software market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Lung cancer screening software market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the lung cancer screening software market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Lung Cancer Screening Software Market Share Analysis

The lung cancer screening software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to lung cancer screening software market.

The major players covered in the lung cancer screening software market report are Medtronic, PenRad Technologies Inc., Koninklijke Philips N.V., Volpara Solutions Limited, Lungview, Siemens Healthcare Private Limited, Thynk Health, Eon, Nuance Communications, Inc., MeVis Medical Solutions AG, HealthMyne, Optellum Ltd, Coreline Soft, Co., Ltd., MyCareWare and ProVation Medical, Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Lung Cancer Screening Software Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions